How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Corgenix, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
23 clearance records and 0 recall records in the covered releases, across 1 source company names and 7 product codes. Dated history runs from Dec 7, 1998 to Apr 4, 2008.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| IGG ANTI-ATHEROX TEST KITK072032 · MSV | Corgenix, Inc. | 510(k) | Apr 4, 2008FDA decision date |
| ASPIRINWORKS TEST KIT (11-DEHYDRO THROMBOXANE B2), MODEL 12136K062025 · OBW | Corgenix, Inc. | 510(k) | May 29, 2007FDA decision date |
| RHIGENE HEP-ANA TEST SYSTEMK042680 · DHN | Corgenix, Inc. | 510(k) | Nov 19, 2004FDA decision date |
| REAADS VON WILLEBRAND FACTOR ACTIVITY TEST KIT, MODEL 10826K032139 · GGP | Corgenix, Inc. | 510(k) | Apr 5, 2004FDA decision date |
| REAADS DSDNA QUANTITATIVE TEST KIT, MODEL 022-001K034013 · LKJ | Corgenix, Inc. | 510(k) | Jan 8, 2004FDA decision date |
| REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139K032868 · MID | Corgenix, Inc. | 510(k) | Oct 14, 2003FDA decision date |
| REAADS IGM ANTI-B2GPI TEST KIT, MODEL 038-001K031208 · MSV | Corgenix, Inc. | 510(k) | Jul 7, 2003FDA decision date |
| MODIFICATION TO REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTATIVE TEST KITK024195 · MID | Corgenix, Inc. | 510(k) | Jan 3, 2003FDA decision date |
| REEADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KITK024196 · MID | Corgenix, Inc. | 510(k) | Jan 3, 2003FDA decision date |
| REAADS IGA ANTI-CARDIOLIPIN SEMI-QUANTITATIVE TEST KIT, MODEL 026-001K022990 · MID | Corgenix, Inc. | 510(k) | Sep 25, 2002FDA decision date |
| REAADS ANTI-CARDIOLIPIN IGG/IGM SEMI-QUANTITATIVE TEST KIT, MODEL 023-001K022992 · MID | Corgenix, Inc. | 510(k) | Sep 25, 2002FDA decision date |
| REAADS ANTI-BETA 2 GLYCOPROTEIN I IGM TEST KITK013077 · MSV | Corgenix, Inc. | 510(k) | Sep 28, 2001FDA decision date |
| REAADS ANTI-BETA 2 GLYCOPROTEIN I IGA TEST KITK013079 · MSV | Corgenix, Inc. | 510(k) | Sep 28, 2001FDA decision date |
| REAADS ANTI-BETA 2 GLYCOPROTEIN I IGG TEST KITK013080 · MSV | Corgenix, Inc. | 510(k) | Sep 28, 2001FDA decision date |
| REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTITIVE TEST KITK013018 · MID | Corgenix, Inc. | 510(k) | Sep 20, 2001FDA decision date |
| MODIFICATION TO: REAADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KITK012567 · MID | Corgenix, Inc. | 510(k) | Aug 23, 2001FDA decision date |
| REAADS IGG ANTI-PROTHROMBIN SEMI-QUANTITATIVE TEST KITK001352 · DHC | Corgenix, Inc. | 510(k) | Apr 9, 2001FDA decision date |
| REAADS IGM ANTI-PROTHROMBIN SEMI-QUANTITATIVE TEST KITK001398 · DHC | Corgenix, Inc. | 510(k) | Mar 30, 2001FDA decision date |
| REAADS IGA ANTI-PHOSPHATIDYLSERINE SEMI-QUANTITATIVE TEST KITK000920 · MID | Corgenix, Inc. | 510(k) | Apr 26, 2000FDA decision date |
| REAADS IGA ANTI-B2GP 1 TEST KITK982434 · MSV | Corgenix, Inc. | 510(k) | Dec 22, 1998FDA decision date |
| REAADS MONOCLONAL FREE PROTEIN S ANTIGEN TEST KITK983914 · GGP | Corgenix, Inc. | 510(k) | Dec 22, 1998FDA decision date |
| REAADS IGG ANTI-B2GPI TEST KITK982391 · MSV | Corgenix, Inc. | 510(k) | Dec 7, 1998FDA decision date |
| REAADS IGM ANTI-B2GP1 TEST KITK982433 · MSV | Corgenix, Inc. | 510(k) | Dec 7, 1998FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.